Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05139927 · ClinicalTrials.gov registry record · NA
Using MOST to Optimize an Intervention to Increase COVID-19 Testing for Frontline Essential Workers
A NA study, sponsored by New York University.
- Completed
- Registry status
- NA
- Development phase
- 438
- Enrollment target
NCT05139927: Completed NA study, sponsored by New York University.
NCT05139927 is a NA study that has completed, run by New York University. The registered enrollment target is 438 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05139927, a NA study, has completed, sponsored by New York University.
- COMPLETED
- Registry status
- NA
- Development phase
- 438 participants
- Enrollment target
Study Summary
COVID-19 testing is essential to controlling the COVID-19 pandemic to break transmission chains and reduce community transmission. However, Black and Latino/Hispanic populations in lower status frontline essential occupations such as food preparation, retail, building maintenance, personal services, and in-home health care have serious barriers to COVID-19 testing and, therefore, insufficient testing rates. The proposed study will use the multiphase optimization strategy framework to address the problem of low COVID-19 testing rates for this population: We will test the effects of four distinct candidate intervention components and then create an efficient multicomponent made up of the most effective combination of the components that can be rapidly scaled up in community settings to boost COVID-19 testing rates.
Primary Outcome
COVID-19 testing at the 6- and/or 12-week follow-up assessment (at least one instance)
Interventions
- BEHAVIORAL Motivational interviewing (MI) counseling
- BEHAVIORAL Text messages (TMs) and quiz questions (QQs)
- BEHAVIORAL Peer education
- BEHAVIORAL Access to COVID testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 438 participants |
| Start Date | 2022-06-01 |
| Est. Completion | 2024-03-01 |
| Phase | NA |
What the finished NCT05139927 record still lists
NCT05139927 is an interventional study that assigns participants to a tested intervention. The registered 438 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower).
The record links to 0 conditions, and to 4 interventions - of which Motivational interviewing (MI) counseling is the first listed.
NCT05139927 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05139927 about?
NCT05139927 is a clinical study titled "Using MOST to Optimize an Intervention to Increase COVID-19 Testing for Frontline Essential Workers". COVID-19 testing is essential to controlling the COVID-19 pandemic to break transmission chains and reduce community transmission. However, Black and Latino/Hispanic populations in lower status frontline essential occupations such as food preparation, retail, building maintenance, personal services,...
What is the current status of trial NCT05139927?
This trial is currently completed. It is a NA study. The enrollment target is 438 participants. The study started on 2022-06-01. Estimated completion is 2024-03-01.
What interventions are being tested in trial NCT05139927?
The interventions under investigation include: Motivational interviewing (MI) counseling (BEHAVIORAL), Text messages (TMs) and quiz questions (QQs) (BEHAVIORAL), Peer education (BEHAVIORAL), Access to COVID testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT05139927?
This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05139927's enrollment target sits among peer trials
438 235th of 2000 higher than 1,766 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05711446 · 438 participants · NA
Double Voiding and Post-transplant UTI
- NCT05421663 · 439 participants · Phase 1
A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma
- NCT06235151 · 439 participants · Phase 3
Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer
- NCT05114538 · 440 participants · NA
Improving the Part C Early Intervention Service Delivery System for Children with ASD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI